Biogen Inc.
BIIB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $20,535,728 | $18,323,581 | $19,964,956 | $22,280,444 |
| - Cash | $3,862,800 | $2,758,800 | $2,598,300 | $2,375,000 |
| + Debt | $6,590,100 | $6,594,600 | $6,621,200 | $6,630,300 |
| Enterprise Value | $23,263,028 | $22,159,381 | $23,987,856 | $26,535,744 |
| Revenue | $2,454,800 | $2,645,500 | $2,431,000 | $2,454,700 |
| % Growth | -7.2% | 8.8% | -1% | – |
| Gross Profit | $1,578,200 | $1,699,300 | $1,853,100 | $1,871,200 |
| % Margin | 64.3% | 64.2% | 76.2% | 76.2% |
| EBITDA | $826,900 | $1,109,900 | $865,100 | $691,700 |
| % Margin | 33.7% | 42% | 35.6% | 28.2% |
| Net Income | $466,500 | $634,800 | $240,500 | $266,700 |
| % Margin | 19% | 24% | 9.9% | 10.9% |
| EPS Diluted | 3.17 | 4.35 | 1.64 | 1.83 |
| % Growth | -27.1% | 165.2% | -10.4% | – |
| Operating Cash Flow | $1,272,500 | $160,900 | $259,300 | $760,900 |
| Capital Expenditures | -$46,200 | -$16,600 | -$47,100 | -$66,300 |
| Free Cash Flow | $1,226,300 | $144,300 | $212,200 | $694,600 |